Pathway Health Corp (CVE:PHC) has signed a collaboration agreement with PharmaChoice Canada for the implementation of its Medical Cannabis Management System (MCMS) in more than 900 independent pharmacies across Canada.
Under the agreement, Pathway said PharmaChoice will be introducing the MCMS service first to more than 250 pharmacies in Ontario under the PharmaChoice, PharmaChoix, and Rx HealthMed banners and then expanding into the balance of locations in Canada throughout the remainder of 2021.
Pathway said the joint initiative has two components -- the first consisting of Pathway providing its accredited continuing education course "Cannabis and Patient Care for Pharmacists", which trains pharmacists in patient assessments and current prescription reviews for contraindications.
READ: Pathway Health receives final exchange approval as it gears up to trade on the TSX Venture Exchange
The second initiative involves the implementation of Pathway's MCMS in PharmaChoice's pharmacy locations across Canada.
Pathway said its MCMS was designed to be implemented in retail pharmacies, with the overarching goals of providing access points for medical cannabis care and enabling pharmacists to offer medical cannabis assessments to appropriate pharmacy patients.
Under the MCMS, patients are then connected to a Pathway physician or nurse practitioner for further evaluation through physical or virtual care. Alternatively, the MCMS allows pharmacies to connect patients through their own affiliated physicians.
The MCMS has also been designed to be integrated into a formal medication review for the pharmacist. The MCMS offers patient assessment tools for the pharmacist, including consent forms, marketing material, back-end patient communication, standard operating procedures, and additional continuing education opportunities.
"We're very excited at the opportunity of working with PharmaChoice Canada and supporting them in their commitment to advancing the health and well-being of Canadians through their community-based locations," said Pathway CEO Ken Yoon in a statement.
Curtis Chafe, director of Pharmacy Services at PharmaChoice Canada, added: "We believe it is essential for Canadians to have access to support from experienced healthcare professionals to help them navigate medical cannabis safely and effectively. Pathway Health is the leader in providing medical cannabis services in Canada and their experience in this area makes them a perfect partner for PharmaChoice."
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham